Nasdaq GlobeNewswire

Chinese tourists can now use Alipay in all 242 Starbucks across Malaysia

Del

HANGZHOU, China, Aug. 24, 2017 (GLOBE NEWSWIRE) -- Alipay, the world's largest online and mobile payment platform operated by Ant Financial Services Group ("Ant Financial", "Ant"), is now available for Mainland Chinese tourists at all 242 Starbucks branches across Malaysia. Chinese tourists can find a nearest Starbucks through the in-app Discovery platform, and pay for their drinks in RMB via Alipay. Alipay and Starbucks Malaysia are also launching a marketing campaign to celebrate the partnership together with Chinese consumers.

Starting from August 18 to October 31, a Chinese tourist using Alipay in Starbucks can enjoy 10% off with cap at RMB 5 yuan and free drink size upgrade at the same time once every week. The customer will also receive a 10%-off e-voucher for future use upon completion of the first transaction. Alipay and Starbucks Malaysia fund the campaign jointly.

"Starbucks is one of the most visited merchants by Chinese tourists in many countries. Through Alipay's Discovery platform, we are leading our users to the nearest Starbucks wherever they are in Malaysia. Getting a cup of familiar coffee with a familiar payment method at a random street corner in Malaysia, will make one's journey as relaxed as at home," said Dayong Zhang, General Manager of Alipay Southeast Asia.

"Now you can use Alipay to pay for your favorite Starbucks beverage at all Starbucks store around Malaysia, including 32 Drive-Thru concept stores and 15 stores in the airport. It is so convenient that customers just have to flash their mobile application at the counter without going through money exchanger to get a cup of coffee. We would like to invite all Alipay users to enjoy their favorite cup of Starbucks beverage during their stay in Malaysia," said Sydney Quays, Chief Executive Officer of Berjaya Food Berhad.

Merchants in Malaysia started to accept Alipay in April 2017 and it's now available in over 5,000 merchants, including over 2,100 7-Eleven stores. Types of merchants include restaurants, bars, supermarkets, department stores, and convenience stores.

Mainland China is the third largest international visitor market for Malaysia. Over 2.12 million Chinese tourists visited Malaysia in 2016 and a year-on-year increase of 8.3% was seen from the first quarter of 2017.

About Alipay 
Operated by Ant Financial Services Group, Alipay is the world's largest mobile and online payment platform. Launched in 2004, Alipay currently has over 520 million active users and over 450 financial institution partners globally. Alipay has evolved from a digital wallet to a lifestyle enabler. Users can hail a taxi, book a hotel, buy movie tickets, pay utility bills, make appointments with doctors, or purchase wealth management products directly from within the app. In addition to online payments, Alipay is expanding to in-store offline payments both inside and outside of China. Over 10 million brick-and-mortar merchants now accept Alipay across China. Alipay's in-store payment service is covering more than 30 countries across the world, and tax reimbursement via Alipay is supported in 24 countries and regions. Alipay works with over 250 overseas financial institutions and payment solution providers to enable cross-border payments for Chinese travelling overseas and overseas customers who purchase products from Chinese e-commerce sites. Alipay currently supports 19 currencies.

About Starbucks Malaysia 
Berjaya Starbucks Coffee Company Sdn Bhd is wholly owned by Berjaya Group Berhad and a licensee of Starbucks Coffee International. The company operates Starbucks retail locations throughout Malaysia and is committed to offering the world's finest coffee while enriching Malaysians' lives one cup at a time. Starbucks Malaysia has been named as Malaysia's best employer at the Aon Hewitt Best Employers- Malaysia 2015 Awards, receiving the title - 'Best of the Best'. Aon Hewitt Best Employers Award is deemed to be one of the most prestigious awards in recognizing companies with high employee engagement, compelling employer brand, effective leadership and high performance culture. In 2014, Starbucks Malaysia has been awarded with the HR Best Practices Gold Award in the Malaysia Human Resources Award 2014 - organized by the Malaysia Institute of Human Resources Management (MIHRM). For more information, please visit the official site at www.starbucks.com.my or check out our Facebook page at www.facebook.com/StarbucksMalaysia and through the Starbucks Newsroom.

Media Enquiries
Xinyun Yang
International Communications
Ant Financial Services Group
Tel: +86 1381 6896 301
Email: xinyun.yang@antfin.com

Salleharon Ahmad
Public Affairs and Digital Strategy
Starbucks Malaysia
Tel: +6 018-2339166
Email: salleharon@starbucks.com.my



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Alipay (UK) Limited via Globenewswire

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Resverlogix Provides Unrestricted Educational Grant for Epigenetic Symposium at International Renal Congress25.5.2018 07:45Pressemelding

CALGARY, Alberta, May 24, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) today announced that on Friday, May 25, 2018, at the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) Congress in Copenhagen, Denmark, the Company is supporting a symposium titled: "Epigenetics in CKD & CVD: A potential breakthrough therapy?" The symposium highlights the role of epigenetics and BET-inhibition in chronic kidney disease and cardiovascular disease, especially in patients with diabetes mellitus, and the significant unmet need that still exists in this patient population. The symposium is co-chaired by Vincent M. Brandenburg, MD - Nephrologist, Aachen, Germany and Kamyar Kalantar-Zadeh, MD - UC Irvine School of Medicine, Irvine, CA, USA, both leading scientists also serving as advisors to Resverlogix's Renal program. The speakers and agenda are as follows: Introduction Vincent M. Brandenburg, MD - University Hospital of the RWTH

Atico Reports Consolidated Financial Results for the First Quarter of 201824.5.2018 22:30Pressemelding

(All amounts expressed in US dollars, unless otherwise stated) VANCOUVER, British Columbia, May 24, 2018 (GLOBE NEWSWIRE) -- Atico Mining Corporation (the "Company" or "Atico") (TSX.V:ATY) (OTC:ATCMF) today announced its financial results for the three months ended March 31, 2018, posting a net income of $0.4 million. Fernando E. Ganoza, CEO and Director, commented, "The strong production and all-in sustaining cash cost of $1.85 achieved this quarter is not reflected in the financial results as a large concentrate shipment was delayed to the second quarter, along with the revenue associated with those tonnes. The shipping schedule is expected to stabilize during the second quarter, where we will then benefit from the additional shipped concentrate and recognized revenue. We anticipate strong financial results in the next quarter." Mr. Ganoza continued, "Our emphasis will continue to be on further strengthening our balance sheet, improving production costs and most importantly regional

Luxembourg Announced as SNOMED International's Newest Member24.5.2018 15:16Pressemelding

London, United Kingdom, May 24, 2018 (GLOBE NEWSWIRE) -- SNOMED International and Agence eSanté Luxembourg are pleased to announce that Luxembourg has joined the organization as its thirty-second Member. Luxembourg, one of the leading nations in the area of information and communication technology, has set the development of eHealth technologies as a high priority. Agence eSanté, Luxembourg's national agency for the exchange and sharing of medical data, has set an overall mission to facilitate clinical information exchange both within Luxembourg and across other international actors. To work towards this reality, the agency has taken part in discussions about standardization across Europe, a contributing building block achieved with its membership in SNOMED International. With their membership, Agence eSanté has committed their support for the use of structured clinical terminology. When applied to the health sector, interoperability ensures that information systems, and through them h

SEMAFO Signs Underground Mining Services Contract with AUMS24.5.2018 14:00Pressemelding

MONTREAL, May 24, 2018 (GLOBE NEWSWIRE) -- SEMAFO Inc. (TSX:SMF) (OMX:SMF) reports that it has signed a mining services contract with African Underground Mining Services ("AUMS") to provide turnkey mining services for Siou underground. AUMS is a well-known and reputable mining contractor with underground experience in Burkina Faso and across Africa. Under the mining services contract, AUMS will be responsible for supplying the mining fleet and a skilled labour force for Siou underground in addition to ensuring development, production and auxiliary services. SEMAFO will provide technical services including geology and engineering as well as leveraging the existing surface infrastructure at Mana. The mining services contract has a term of 70 months. The economic terms of the mining services contract are consistent with the economics presented in the Mana pre-feasibility study filed March 29, 2018 on SEDAR. Preparatory work has already commenced on Siou underground with full project deplo

Merus Announces First Patient Dosed in Phase 1 Clinical Trial of MCLA-158 in Patients with Solid Tumors24.5.2018 13:00Pressemelding

- IND Accepted in April by the U.S. FDA for MCLA-158 - UTRECHT, The Netherlands, May 24, 2018 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq:MRUS), a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics (Biclonics®), today announced that the first patient has been dosed in a Phase 1, first-in human clinical trial of MCLA-158 in patients with solid tumors with an initial focus on metastatic colorectal cancer. The trial will be conducted in Europe, where several Clinical Trial Applications (CTAs) have been approved to date. The Company also announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for MCLA-158, which was accepted by the FDA in April 2018. With this acceptance, Merus plans to open additional sites for this trial in the United States. MCLA-158 is designed to bind to cancer stem cells expressing leucine-rich repeat-containing G protein-coupled receptor 5 (Lgr5) and epidermal grow

PRA Named International Clinical Research Company of the Year24.5.2018 10:00Pressemelding

RALEIGH, N.C., May 24, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce it was recognized by PharmaTimes as the International Clinical Research Company of the Year. This is the fifth year in a row that PRA has received this award. "This award celebrates excellence in the clinical research industry and we are honored to once again be recognized by our peers," said Colin Shannon, President and Chief Executive Officer. "This award is possible thanks to the incredibly talented PRA team members we have working around the world who are deeply committed to their work in bringing new and life-saving therapies to the patients who need them." PRA also swept the Clinical Research Associate and Clinical Trial Administrator categories capturing a total of 11 awards. These awards follow PRA's recognition earlier this month in the PharmaTimes Americas competition where PRA also received 11 awards, including Company of the Year. The PharmaTimes, International Cli

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom